Copyright: ©Author(s) 2027.
World J Gastroenterol. Jan 14, 2027; 33(2): 127120
Published online Jan 14, 2027. doi: 10.3748/wjg.127120
Published online Jan 14, 2027. doi: 10.3748/wjg.127120
Table 3 Comparison of clinical outcomes between interval and sporadic colorectal cancers, before and after propensity score weighting
| Before PSW | After PSW | ||||||||
| Interval CRC (n = 28) | Sporadic CRC (n = 79) | P value | SMD | Interval CRC (n = 23.60) | Sporadic CRC (n = 67.48) | P value | SMD | ||
| 1st line treatment | 0.011 | 0.701 | 0.250 | 0.401 | |||||
| Endoscopic treatment | 3 (10.7) | 1 (1.3) | 0.8 (3.3) | 0.7 (1.1) | |||||
| Colectomy | 22 (78.6) | 73 (92.4) | 22.0 (93.3) | 63.0 (93.4) | |||||
| Chemotherapy | 1 (3.6) | 1 (1.3) | 0.3 (1.1) | 0.8 (1.1) | |||||
| Radiation therapy | 0 (0.0) | 4 (5.1) | 0 (0.0) | 3.0 (4.4) | |||||
| Chemoradiation therapy | 2 (7.1) | 0 (0.0) | 0.5 (2.2) | 0 (0.0) | |||||
| Stage | 0.004 | 0.791 | 0.177 | 0.743 | |||||
| I | 13 (46.3) | 11 (13.9) | 10.2 (43.3) | 10.8 (16.1) | |||||
| II | 8 (28.6) | 28 (35.4) | 7.4 (31.2) | 24.7 (36.6) | |||||
| III | 5 (17.9) | 27 (34.2) | 5.5 (23.2) | 21.4 (31.7) | |||||
| IV | 2 (7.1) | 13 (16.5) | 0.5 (2.3) | 10.6 (15.7) | |||||
| Death | Yes | 8 (28.6) | 22 (27.8) | 0.942 | 0.653 | 5.1 (21.4) | 17.9 (26.5) | 0.715 | 0.119 |
| Overall survival | Months, mean | 88.09 (53.88) | 61.25 (21.80) | < 0.001 | 0.653 | 87.96 (41.20) | 61.17 (26.5) | 0.032 | 0.813 |
- Citation: Song JH, Shin JE, Kim DS, Lee YJ, Yang HC, Kim KO, Kim JH, Kang GH, Shim SR, Huh KC. Clinicopathologic and biomolecular features of interval colorectal cancers in Korean patients: A KASID multicenter prospective study. World J Gastroenterol 2027; 33(2): 127120
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/127120.htm
- DOI: https://dx.doi.org/10.3748/wjg.127120